Cyclists Have Weaker Bones Than Sedentary Adults: The Two Non-Cycling Habits That Cut Osteopenia Risk 40 Percent
A peer-reviewed scoping review found that 84 percent of competitive cyclists meet criteria for osteopenia or osteoporosis.
Health
Endurance Cyclists Are 2 to 10 Times More Likely to Develop Atrial Fibrillation : The Screening Protocol Every Masters Rider Needs
September 11, 2026
It also produces a specific arrhythmia risk that shows up disproportionately in male masters riders with long endurance histories.
Cycling is unusually good for cardiovascular health. Masters cyclists show reduced all-cause mortality, better blood pressure profiles, and lower rates of coronary artery disease than sedentary populations of the same age.
That is the consistent message the sport tells about itself.
There is a second message the sport tells much less often. Long-term endurance cyclists have a 2 to 10 times higher prevalence of atrial fibrillation compared to age-matched non-athletes, according to the peer-reviewed literature.
The risk is dose-dependent, meaning riders with the most years and the highest training volumes face the highest risk.
John Mandrola, an electrophysiologist, competitive cyclist, and prominent public voice on endurance-athlete heart health, has spent years arguing that this second message deserves the same attention as the first. AFib is not usually life-threatening, but it is life-altering, and it is often preventable through screening choices that most cyclists never make.
The gap between the cardiology literature and what masters cyclists actually know about their own hearts is one of the sport's quiet risk gaps.
What the Peer-Reviewed Evidence Actually Shows
A 2024 review published in the Reviews in Cardiovascular Medicine journal examined the association between endurance sports and atrial fibrillation, drawing on epidemiological data across cyclists, cross-country skiers, and long-distance runners. The full review is available on PubMed Central.
The findings are consistent across the literature. Male endurance athletes over 40 with more than 10 years of high-volume training show approximately 2 to 10 times higher AFib prevalence compared to matched non-athletic controls.
The mechanism is a combination of structural, electrical, and autonomic changes that develop over decades of sustained endurance training.
Atrial dilation as the left atrium enlarges to handle years of high cardiac output. Atrial fibrosis as microscopic scar tissue accumulates from years of inflammatory response to hard training. Autonomic imbalance as elevated vagal tone (a marker of endurance fitness) creates conditions that favor arrhythmic triggering.
None of these changes is a disease. All of them are adaptations to the training itself. The problem is that the same adaptations that make you fast also create the electrical substrate that predisposes to atrial arrhythmia.
The typical AFib patient in the endurance cardiology clinic is a middle-aged, tall, lean man with more than a decade of high-volume endurance training. That profile describes a substantial slice of the recreational road cycling population.
The Symptoms Most Cyclists Miss or Explain Away
Atrial fibrillation is often subtle, and cyclists have a particular tendency to dismiss the early warning signs.
Palpitations after hard efforts. Feeling your heart flutter or pound irregularly for a few minutes at the end of a threshold interval, then settling back to normal. Easy to attribute to intensity or dehydration. Sometimes it is. Sometimes it is early AFib.
Sudden unexplained fatigue. A ride where your power inexplicably drops 30 to 50 watts below normal, or where you feel like you cannot sustain efforts that would normally be routine. This can be a signal that your heart is not pumping efficiently, which happens during AFib episodes even when you do not feel the arrhythmia directly.
Chest tightness or breathlessness disproportionate to effort. Not the normal breathing hard at threshold. A specific sense that you cannot get enough air in, or that your chest feels compressed, at intensities that should be manageable.
Dizziness or near-syncope during exertion. This is the symptom that finally sends riders to a cardiologist. It also is the symptom that indicates the AFib is affecting cardiac output significantly enough to reduce brain perfusion.
Our earlier piece on cardiac drift, why your heart rate climbs on long rides covers a different but related phenomenon that riders sometimes confuse with early arrhythmia. Cardiac drift is normal physiology; sudden erratic rate changes during effort are not.
The Screening Protocol Mandrola Recommends
Standard cardiac screening at annual physicals does not typically catch AFib in endurance athletes. Resting ECGs are normal in most AFib patients between episodes.
By the time a resting ECG catches the arrhythmia, it usually means the AFib is either persistent or occurring frequently enough to be found by chance.
Mandrola's public writing and podcast appearances consistently emphasize a more proactive screening approach for masters endurance athletes.
Wearable arrhythmia detection. Modern smartwatches with ECG capability (Apple Watch, certain Garmin models, Fitbit Sense) can detect and record AFib episodes when they occur.
This is genuinely useful screening technology for cyclists, because it captures episodes that would otherwise go undocumented.
Post-effort heart rate monitoring. After hard sessions or races, check whether your heart rate returns to normal within the expected recovery window (typically 60 to 100 bpm within 5 minutes). Sustained elevated or irregular rates warrant investigation.
Baseline echocardiogram at 50. For masters cyclists with more than 15 years of endurance training history, a baseline echo establishes cardiac chamber dimensions and rules out structural issues. Serial echos every 3 to 5 years track changes over time.
Ambulatory rhythm monitoring if symptoms appear. A 14 to 30 day event monitor is the gold standard for catching intermittent AFib. It is what a competent electrophysiologist orders when a cyclist presents with the symptoms above.
What to Do If You Get Diagnosed
An AFib diagnosis is not the end of your cycling career. Many prominent endurance athletes have continued training and racing after AFib diagnosis and treatment, though usually with modifications.
Rate-control medications can manage symptoms without eliminating exercise capacity, but some beta-blockers substantially reduce peak power output and are poorly tolerated by trained cyclists.
Catheter ablation has become the definitive treatment for many symptomatic patients. Success rates for pulmonary vein isolation in athletes are similar to those in the general population, and many patients return to full training within weeks.
Anticoagulation decisions depend on age and stroke risk factors, and are more nuanced in otherwise-healthy athletes than in typical AFib populations.
Any of these decisions belong with an electrophysiologist experienced with athletes, not with a general cardiologist. The management is different, and the athletic-population evidence base has grown substantially in the past decade.
The Broader Cardiovascular Health Picture for Masters Cyclists
AFib is not the only cardiac finding that appears disproportionately in masters endurance athletes. Male masters cyclists show increased coronary artery calcification compared to sedentary controls in some studies, though the clinical significance of this is debated.
Female masters cyclists show a different risk profile, with less coronary calcium accumulation but similar or slightly elevated AFib risk compared to non-athletic peers. The sex-based cardiac differences in masters endurance athletes are only now being systematically studied.
For cyclists worried about clot-related risks from long-duration training and travel, our earlier piece on deep vein thrombosis in cyclists, the hidden health risk of endurance cycling covers a related but distinct concern that shares some of the same overlooked-condition dynamics as AFib.
Where This Guidance Falls Short
The AFib-endurance-training association is well-documented but not universal. Many lifelong cyclists never develop atrial arrhythmia. Individual susceptibility varies substantially based on genetics, atrial anatomy, and other factors that current screening cannot predict.
The optimal training-volume threshold above which AFib risk rises meaningfully is not clearly established. The literature suggests roughly 1,500 to 2,000 lifetime training hours as an inflection point, but individual variation is large.
Data on female masters cyclists is sparser than for male athletes. Emerging evidence suggests women may have lower AFib risk than men at equivalent training loads, but sample sizes remain limited.
None of this should be read as an argument against endurance cycling. The all-cause mortality benefits of consistent aerobic training substantially outweigh the AFib risk for almost every rider. But being informed about the risk allows earlier detection when it does appear.
The Screening Habits Every Masters Cyclist Should Adopt
The practical implications are straightforward and cheap to implement.
Get a smartwatch with ECG capability if you are over 45 with a long training history. Enable AFib notifications. Record any suspicious episodes and share the recordings with your doctor.
Track your resting heart rate consistently. Sudden sustained elevation without training-load explanation warrants investigation. Falling resting heart rate below your normal baseline can also be a warning sign of overtraining or, occasionally, of conduction changes.
Book a baseline echocardiogram if you have more than 15 years of endurance training and have never had one. Repeat every 3 to 5 years.
Learn your symptom pattern. Note when palpitations occur, how long they last, and what triggers them. This information is what allows an electrophysiologist to make an accurate diagnosis quickly.
Find an electrophysiologist experienced with athletes before you need one. The evaluation you get from an athletic-population specialist will be substantially different, and better, than the evaluation from a general cardiologist.
The 2 to 10 times AFib risk figure is not a reason to stop riding. It is a reason to be a smarter, better-screened cyclist as you accumulate years in the sport.
The riders who catch AFib early have significantly more treatment options, better outcomes, and higher likelihood of returning to full training than the riders who present in emergency rooms after their first serious episode.
Screening habits are the difference.
Become a Confident Cyclist in 5 Days
Perfect for the new riders!
No spam. Cancel anytime.
